Inhibitor ribonukleotidne reduktaze

Izvor: Wikipedija
(Preusmjereno sa stranice Inhibitori ribonukleotid reduktaze)
Prijeđi na navigaciju Prijeđi na pretragu

Inhibitori ribonukleotidne reduktaze su familija antikancerni lekovi koji ometaju rast ćelija tumora blokiranjem formiranja dezoksiribonukleotida (gradivnih blokova DNK).

Primeri

Reference[uredi | uredi kod]

  1. Zahedi Avval F, Berndt C, Pramanik A, Holmgren A (January 2009). „Mechanism of inhibition of ribonucleotide reductase with motexafin gadolinium (MGd)”. Biochem. Biophys. Res. Commun. 379 (3): 775–9. DOI:10.1016/j.bbrc.2008.12.128. PMID 19121624. 
  2. Mayhew CN, Phillips JD, Cibull ML, Elford HL, Gallicchio VS (September 2002). „Short-term treatment with novel ribonucleotide reductase inhibitors Trimidox and Didox reverses late-stage murine retrovirus-induced lymphoproliferative disease with less bone marrow toxicity than hydroxyurea”. Antivir. Chem. Chemother. 13 (5): 305–14. PMID 12630679. 
  3. Tsimberidou AM, Alvarado Y, Giles FJ (August 2002). „Evolving role of ribonucleoside reductase inhibitors in hematologic malignancies”. Expert Rev Anticancer Ther 2 (4): 437–48. DOI:10.1586/14737140.2.4.437. PMID 12647987. 
  4. Bernstein LR (1998). „Mechanisms of therapeutic activity for gallium”. Pharmacol. Rev. 50 (4): 665–682. PMID 9860806. Arhivirano iz originala na datum 2007-02-26. Pristupljeno 2014-07-08. 

Vidi još[uredi | uredi kod]

Vanjske veze[uredi | uredi kod]